DEN240071 - neuropacs (FDA 510(k) Clearance)

DEN240071 is an FDA 510(k) submission (not cleared) for the neuropacs.

Submitted by Automated Imaging Diagnostics, LLC (Gainesville, US). The FDA issued a Not Cleared (DENG) decision on April 3, 2026 after a review of 485 days.

This device falls under the Neurology FDA review panel. The Traditional 510(k) pathway requires demonstration of substantial equivalence to a legally marketed predicate device - a standard the FDA determined was not met in this submission.

Device pattern: Regulatory edge-case submission. High predicate equivalence gap. With 485 days under review and no clearance granted, this submission reflects a case where the FDA could not confirm sufficient predicate equivalence - often indicating either a novel device category or unresolved safety and performance questions.

View all Automated Imaging Diagnostics, LLC devices